India’s weight-loss jabs now within the reach of millions

India is witnessing a significant shift in its battle against obesity and diabetes, thanks to the increasing availability of affordable generic weight loss medication like semaglutide. These medications, which were previously out of reach for millions of Indians due to high costs, are now becoming more accessible, particularly with the entry of generic versions. This development is expected to have a substantial impact on the country's healthcare landscape, where obesity and diabetes are among the leading causes of morbidity and mortality. With semaglutide and similar medications now within the reach of millions, Indians can look forward to improved management of their weight and blood sugar levels, leading to a better quality of life and reduced healthcare costs in the long run. As the Indian government continues to prioritize healthcare and make essential medications more affordable, it is likely that the country will see a significant reduction in the prevalence of obesity and diabetes in the coming years.